Anna Gavin

23.8k total citations · 4 hit papers
197 papers, 7.3k citations indexed

About

Anna Gavin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Economics and Econometrics. According to data from OpenAlex, Anna Gavin has authored 197 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 126 papers in Oncology, 64 papers in Pulmonary and Respiratory Medicine and 32 papers in Economics and Econometrics. Recurrent topics in Anna Gavin's work include Global Cancer Incidence and Screening (84 papers), Colorectal Cancer Screening and Detection (38 papers) and Prostate Cancer Diagnosis and Treatment (33 papers). Anna Gavin is often cited by papers focused on Global Cancer Incidence and Screening (84 papers), Colorectal Cancer Screening and Detection (38 papers) and Prostate Cancer Diagnosis and Treatment (33 papers). Anna Gavin collaborates with scholars based in United Kingdom, Ireland and Netherlands. Anna Gavin's co-authors include Freddie Bray, Jacques Ferlay, Manola Bettio, Giorgia Randi, Isabelle Soerjomataram, Liam Murray, Otto Visser, Murielle Colombet, T Dyba and Helen G. Coleman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Anna Gavin

192 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018

2018 1.7k citations Jacques Ferlay, Giorgia Randi et al. European Journal of Cancer profile →
Risk of Malignant Progression in Barrett's Esophagus Patients: Results from a Large Population-Based Study

2011 498 citations Helen G. Coleman, Damian McManus et al. profile →
The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers

2021 374 citations Tadeusz Dyba, Giorgia Randi et al. European Journal of Cancer profile →
The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015

2018 357 citations Anna Gavin, Dyfed Huws et al. British Journal of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Gavin United Kingdom	38	3.2k	2.3k	1.8k	915	790	197	7.3k
Harry Comber Ireland	32	3.2k 1.0×	1.9k 0.8×	1.6k 0.9×	1.2k 1.3×	839 1.1×	103	7.0k
David Brewster United Kingdom	47	3.5k 1.1×	1.8k 0.8×	1.5k 0.9×	804 0.9×	670 0.8×	160	7.7k
Martin Krapcho United States	10	3.6k 1.1×	2.0k 0.9×	1.3k 0.7×	1.3k 1.4×	1.0k 1.3×	14	8.2k
Hannah K. Weir United States	38	3.9k 1.2×	1.9k 0.8×	1.3k 0.7×	1.4k 1.6×	1.1k 1.3×	84	8.1k
Matt Hayat United States	5	3.3k 1.0×	1.9k 0.8×	1.2k 0.7×	1.3k 1.4×	956 1.2×	6	7.9k
Marie‐Josèphe Horner United States	11	3.6k 1.1×	1.9k 0.8×	1.3k 0.7×	1.3k 1.4×	993 1.3×	26	8.2k
Milena Sant Italy	37	4.5k 1.4×	1.6k 0.7×	1.4k 0.8×	989 1.1×	1.2k 1.5×	126	8.3k
Allan Hackshaw United Kingdom	50	2.3k 0.7×	1.7k 0.8×	1.9k 1.1×	1.3k 1.4×	783 1.0×	202	10.7k
Paul W. Dickman Sweden	59	4.0k 1.2×	1.8k 0.8×	2.1k 1.2×	1.2k 1.3×	959 1.2×	198	12.5k
Christie R. Eheman United States	25	3.9k 1.2×	1.7k 0.7×	1.0k 0.6×	1.2k 1.3×	953 1.2×	47	7.4k

Countries citing papers authored by Anna Gavin

Since Specialization

Citations

This map shows the geographic impact of Anna Gavin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Gavin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Gavin more than expected).

Fields of papers citing papers by Anna Gavin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Gavin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Gavin. The network helps show where Anna Gavin may publish in the future.

Co-authorship network of co-authors of Anna Gavin

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Gavin. A scholar is included among the top collaborators of Anna Gavin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Gavin. Anna Gavin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lohfeld, Lynne, Damien Bennett, Anna Gavin, et al.. (2024). Correction: Impact of the COVID-19 pandemic on breast cancer patient pathways and outcomes in the United Kingdom and the Republic of Ireland – a scoping review. British Journal of Cancer. 131(4). 778–778. 2 indexed citations

Greene, Giles, C S Thomson, David Donnelly, et al.. (2023). Whole-population trends in pathology-confirmed cancer incidence in Northern Ireland, Scotland and Wales during the SARS-CoV-2 pandemic: A retrospective observational study. Cancer Epidemiology. 84. 102367–102367. 5 indexed citations

Walls, Gerard, John D. O’Connor, Mark Harbinson, et al.. (2023). Association between statin therapy dose intensity and radiation cardiotoxicity in non-small cell lung cancer: Results from the NI-HEART study. Radiotherapy and Oncology. 186. 109762–109762. 12 indexed citations

Giusti, Francesco, Carmen Martos, Annalisa Trama, et al.. (2023). Cancer treatment data available in European cancer registries: Where are we and where are we going?. Frontiers in Oncology. 13. 1109978–1109978. 15 indexed citations

Mitchell, Helen, et al.. (2023). Impact of COVID-19 control on lung, breast, and colorectal pathological cancer diagnoses. A comparison between the Netherlands, Aotearoa New Zealand, and Northern Ireland. BMC Cancer. 23(1). 700–700. 5 indexed citations

Brett, Jo, Zoe Davey, Hugh Butcher, et al.. (2022). Impact of patient and public (PPI) involvement in the Life After Prostate Cancer Diagnosis (LAPCD) study: a mixed-methods study. BMJ Open. 12(11). e060861–e060861. 4 indexed citations

Dyba, Tadeusz, Giorgia Randi, Freddie Bray, et al.. (2021). The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers. European Journal of Cancer. 157. 308–347. 374 indexed citations breakdown →

Cavers, Debbie, Annemieke Bikker, Karen Barnett, et al.. (2019). BPOS Oral Presentations. Psycho-Oncology. 28(S2). 3–8. 2 indexed citations

Retzer, Ameeta, Thomas Keeley, Khaled Ahmed, et al.. (2018). Evaluation of patient-reported outcome protocol content and reporting in UK cancer clinical trials: the EPiC study qualitative protocol. BMJ Open. 8(2). e017282–e017282. 7 indexed citations

10.

Donnelly, Conan, Nigel Hart, Lesley Anderson, et al.. (2017). Knowledge or noise? Making sense of General Practitioners’ and Consultant use of 2-week-wait referrals for suspected cancer. British Journal of Cancer. 117(5). 597–603. 1 indexed citations

11.

Coyle, Catherine, Eileen Morgan, Frances J. Drummond, Linda Sharp, & Anna Gavin. (2017). Do men regret prostate biopsy: Results from the PiCTure study. BMC Urology. 17(1). 11–11. 5 indexed citations

12.

Weller, David, Peter Vedsted, Chantelle Anandan, et al.. (2016). An investigation of routes to cancer diagnosis in 10 international jurisdictions, as part of the International Cancer Benchmarking Partnership: survey development and implementation. BMJ Open. 6(7). e009641–e009641. 36 indexed citations

13.

Drummond, Frances J., Heather Kinnear, Conan Donnelly, et al.. (2015). Establishing a population-based patient-reported outcomes study (PROMs) using national cancer registries across two jurisdictions: the Prostate Cancer Treatment, your experience (PiCT ure ) study. BMJ Open. 5(4). e006851–e006851. 23 indexed citations

14.

Coleman, Helen G., Maurice B. Loughrey, Liam Murray, et al.. (2015). Colorectal Cancer Risk Following Adenoma Removal: A Large Prospective Population-Based Cohort Study. Cancer Epidemiology Biomarkers & Prevention. 24(9). 1373–1380. 33 indexed citations

15.

Bannon, Finian, Jennifer A. McCaughan, Carol Traynor, et al.. (2014). Surveillance of Nonmelanoma Skin Cancer Incidence Rates in Kidney Transplant Recipients in Ireland. Transplantation. 98(6). 646–652. 12 indexed citations

16.

Bhat, Shivaram, Damian McManus, Helen G. Coleman, et al.. (2014). Oesophageal adenocarcinoma and prior diagnosis of Barrett's oesophagus: a population-based study. Gut. 64(1). 20–25. 101 indexed citations

17.

Carney, Patricia A., Anna Gavin, & Ciarán O’Neill. (2013). The role of private care in the interval between diagnosis and treatment of breast cancer in Northern Ireland: an analysis of Registry data. BMJ Open. 3(12). e004074–e004074. 10 indexed citations

18.

Autier, Philippe, et al.. (2010). Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ. 341(aug11 1). c3620–c3620. 284 indexed citations

19.

Cantwell, Marie M., Liam Murray, David Donnelly, et al.. (2009). Second primary cancers in patients with skin cancer: a population-based study in Northern Ireland. British Journal of Cancer. 100(1). 174–177. 39 indexed citations

20.

Anderson, Lesley, L. J. Murray, Stephen Murphy, et al.. (2003). Mortality in Barrett’s oesophagus: results from a population based study. Gut. 52(8). 1081–1084. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact